EcoDrugPlus

Retinoic Acid Receptor Beta

Ensembl ID : ENSCHOG00000008395
Gene Symbol: RARB
1 Cross references
451 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSCHOG00000009975
Gene Symbol: RXRB
1 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSCHOG00000009952
Gene Symbol: RXRG
1 Cross references
277 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSCHOG00000006732
Gene Symbol: RPL12
1 Cross references
428 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSCHOG00000009404
Gene Symbol: RPL14
1 Cross references
287 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSCHOG00000007872
Gene Symbol: RPL17
1 Cross references
715 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSCHOG00000009140
Gene Symbol: RPL18
1 Cross references
276 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSCHOG00000006023
Gene Symbol: RPL19
1 Cross references
247 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSCHOG00000007477
Gene Symbol: RPL22
1 Cross references
233 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSCHOG00000009153
Gene Symbol: RPL23
1 Cross references
265 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSCHOG00000004703
Gene Symbol: RPL26
1 Cross references
263 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSCHOG00000008145
Gene Symbol: RPL31
1 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).